Browse by Journal Title

Article

Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII.
Sarafanov, A.G., Makogonenko, E.M., Andersen, O.M., Mikhailenko, I.A., Ananyeva, N.M., Khrenov, A.V., Shima, M., Strickland, D.K. and Saenko, E.L.
Thrombosis and Haemostasis 98 (6): 1170-1181. December 2007

Intraoperative fresh-frozen plasma versus human albumin in craniofacial surgery - a pilot study comparing coagulation profiles in infants younger than 12 months.
Hildebrandt, B., Machotta, A., Riess, H., Kerner, S., Ahlers, O., Haberl, H., Doerken, B. and Kerner, T.
Thrombosis and Haemostasis 98 (1): 172-7. July 2007

Effect of surface modified liposomes on the aggregation of platelets and tumor cells.
Keil, C., Zeisig, R. and Fichtner, I.
Thrombosis and Haemostasis 94 (2): 404-411. August 2005

Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signalling pathway.
Kiian, I., Tkachuk, N., Haller, H. and Dumler, I.
Thrombosis and Haemostasis 89 (5): 904-914. May 2003

Ventricular remodeling after acute myocardial infarction.
Dietz, R., Osterziel, K.J., Willenbrock, R., Gulba, D.C. and von Harsdorf, R.
Thrombosis and Haemostasis 82 (Suppl 1): 73-75. September 1999

Treatment of carotid artery stenosis by elective stent placement instead of carotid endarterectomy in patients with severe coronary artery disease.
Gross, C.M., Kraemer, J., Uhlich, F., Tamaschke, C., Vogel, P., Friedrich, I., Dietz, R. and Waigand, J.
Thrombosis and Haemostasis 82 (Suppl 1): 176-180. September 1999

Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach.
Gulba, D.C.
Thrombosis and Haemostasis 82 (2): 953-961. August 1999

Transcriptional regulation of the murine urokinase-type plasminogen activator gene in skeletal myoblasts.
Miralles, F., Ibanez-Tallon, I., Parra, M., Crippa, M., Blasi, F., Besser, D., Nagamine, Y. and Munoz-Canoves, P.
Thrombosis and Haemostasis 81 (5): 767-774. May 1999

Sulfated polysaccharide anticoagulants suppress natural killer cell activity in vitro.
Johann, S., Zoller, C., Haas, S., Bluemel, G., Lipp, M. and Foerster, R.
Thrombosis and Haemostasis 74 (4): 998-1002. October 1995

Characterization of human tissue-type plasminogen activator with monoclonal antibodies - mapping of epitopes and binding sites for fibrin and lysine.
Zacharias, U., Fischer, B., Noll, F. and Will, H.
Thrombosis and Haemostasis 67 (1): 88-94. 23 January 1992

Letter

Protease-activated receptor-1 IgG autoantibodies in patients with COVID-19.
Reinshagen, L., Nageswaran, V., Heidecke, H., Schulze-Forster, K., Wilde, A.C.B., Ramezani Rad, P., Poller, W., Asmus, E., Simmons, S., Kuebler, W.M., Witzenrath, M., Marko, L., Jakobs, K., Leistner, D.M., Rauch-Kröhnert, U., Kränkel, N., Forslund, S.K., Landmesser, U., Müller, D.N. and Haghikia, A.
Thrombosis and Haemostasis 6 November 2023 (In Press)

Interruption of the CXCL13/CXCR5 chemokine axis enhances plasma IgM levels and attenuates atherosclerosis development.
van der Vorst, E.P.C., Daissormont, I., Aslani, M., Seijkens, T., Wijnands, E., Lutgens, E., Duchene, J., Santovito, D., Döring, Y., Halvorsen, B., Aukrust, P., Weber, C., Höpken, U.E. and Biessen, E.A.L.
Thrombosis and Haemostasis 120 (2): 344-347. February 2020

Thrombospondin-4 Ala387Pro polymorphism is not associated with vascular function and risk of coronary heart disease in US men and women.
Asselbergs, F.W., Pai, J.K., Pischon, T., Manson, J.E. and Rimm, E.B.
Thrombosis and Haemostasis 95 (3): 589-590. March 2006